Back to ACET

Carlyle Group Inc. → ACET

Carlyle Group Inc. ACET Position History

Adicet Bio, Inc.

Quarters held
12
Latest value
$1.6M
Q2 2026
Peak value
$12.2M
First seen
Q1 2023

Dollar value over time

Show data table
PeriodPosition value
Q1 2023$12.2M
Q2 2023$5.1M
Q3 2023$2.9M
Q4 2023$4M
Q1 2024$6.9M
Q2 2024$3.6M
Q3 2024$4.2M
Q4 2024$2.8M
Q1 2025$2.3M
Q2 2025$1.8M
Q3 2025$2.4M
Q2 2026$1.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$1.6M184.3K——
Q3 2025$2.4M2.95M——
Q2 2025$1.8M2.95M——
Q1 2025$2.3M2.95M——
Q4 2024$2.8M2.95M——
Q3 2024$4.2M2.95M——
Q2 2024$3.6M2.95M——
Q1 2024$6.9M2.95M——
Q4 2023$4M2.12M——
Q3 2023$2.9M2.12M——
Q2 2023$5.1M2.12M——
Q1 2023$12.2M2.12M——

Other funds holding ACET

Other Carlyle Group Inc. positions

MDLN

Medline Inc

$9B
MDLN

Medline Inc

$8.3B
MDLN

Medline Inc

$7.4B
SARO

Standardaero Inc

$2.5B
SARO

Standardaero Inc

$2.2B
QDEL

Quidelortho Corp

$1.1B
QDEL

Quidelortho Corp

$1B
GTM

ZoomInfo Technologies Inc

$930.9M